News
Keep up with us at Mercodia
Mercodia announces the appointment of Helena Åsbrink as interim Chief Executive Officer, effective 2 November 2026. With more than 20 years of international leadership experience in life science, Åsbr...
READ MORE
From 1 November 2026, Mercodia will introduce separate In Vitro Diagnostic (IVD) and Research Use Only (RUO) product versions. The Mercodia IVD and RUO product labeling update will provide greater cla...
READ MORE
We are pleased to announce a new distribution partnership with AdviSains, strengthening Mercodia’s presence in Indonesia and improving local access to our high-quality immunoassays and dedicated custo...
READ MORE
Mercodia has launched a new On-demand IAPP ELISA for the quantitative measurement of IAPP (islet amyloid polypeptide), also known as amylin, in human plasma samples. With high sensitivity for low circ...
READ MORE
We are pleased to announce a new distribution partnership with XL Biotec, strengthening Mercodia’s presence in Thailand and improving local access to our high-quality immunoassays and dedicated ...
READ MORE
Mercodia announces the launch of the Mercodia Metabolic Research Award, an international initiative recognizing outstanding and innovative contributions within metabolic disease research. supporting t...
READ MORE
New distribution partnership with Celtic Molecular Diagnostics in Africa We are pleased to announce a new distribution partnership with Celtic Molecular Diagnostics, strengthening Mercodia’s presence ...
READ MORE
Mercodia Moves Into Upside Stories in Uppsala Mercodia has signed a lease agreement at Upside Stories, Vectura’s new innovation environment in central Uppsala. As the first company to establish itself...
READ MORE
New Assay Launch: HNL Homodimer ELISA Mercodia proudly introduces the HNL Homodimer ELISA (10-1380-01) – a cutting-edge immunoassay designed to measure the neutrophil-specific homodimeric form of Huma...
READ MORE